In addition, cell viability assays showed that cisplatin-treated CAPRIN1 overexpressing Hep-2 cells exhibited higher cell viabilities and numbers of colonies as compared to those normal Hep-2 cells (Figures 2(g) and 2(h)), indicating CAPRIN1 overexpressing promoted cisplatin resistance in laryngeal cancer cells. The gene discussed is CAPRIN1; the disease is laryngeal carcinoma.